Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors-Reference-Cited by-同舟云学术

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Published:2020-02-06 Issue:6 Volume:382 Page:545-553
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Liu Enli¹,Marin David¹,Banerjee Pinaki¹,Macapinlac Homer A.¹,Thompson Philip¹,Basar Rafet¹,Nassif Kerbauy Lucila¹,Overman Bethany¹,Thall Peter¹,Kaplan Mecit¹,Nandivada Vandana¹,Kaur Indresh¹,Nunez Cortes Ana¹,Cao Kai¹,Daher May¹,Hosing Chitra¹,Cohen Evan N.¹,Kebriaei Partow¹,Mehta Rohtesh¹,Neelapu Sattva¹,Nieto Yago¹,Wang Michael¹^ORCID,Wierda William¹,Keating Michael¹,Champlin Richard¹,Shpall Elizabeth J.¹,Rezvani Katayoun¹

Affiliation:

1. From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston.

Funder

M.D. Anderson Cancer Center CLL and lymphoma Moonshot Grants

National Institutes of Health

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1910607

Cited by 1212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Me2SO-free cryopreservation medium and its long-term cryoprotection on the CAR-NK cells;Cryobiology;2024-03

2. Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma;Transplantation and Cellular Therapy;2024-02

3. Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death;Cell;2024-02

4. Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma;Frontiers in Immunology;2024-01-29

5. Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells;Cells;2024-01-28